GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » COGS-to-Revenue

HLB Panagene Co (XKRX:046210) COGS-to-Revenue : 0.29 (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co COGS-to-Revenue?

HLB Panagene Co's Cost of Goods Sold for the three months ended in Jun. 2024 was ₩722 Mil. Its Revenue for the three months ended in Jun. 2024 was ₩2,464 Mil.

HLB Panagene Co's COGS to Revenue for the three months ended in Jun. 2024 was 0.29.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. HLB Panagene Co's Gross Margin % for the three months ended in Jun. 2024 was 70.68%.


HLB Panagene Co COGS-to-Revenue Historical Data

The historical data trend for HLB Panagene Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co COGS-to-Revenue Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.33 0.32 0.32 0.33

HLB Panagene Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.28 0.27 0.25 0.29

HLB Panagene Co COGS-to-Revenue Calculation

HLB Panagene Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4028.894 / 12252.031
=0.33

HLB Panagene Co's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=722.221 / 2463.637
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Panagene Co  (XKRX:046210) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

HLB Panagene Co's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 722.221 / 2463.637
=70.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


HLB Panagene Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co Business Description

Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co Headlines

No Headlines